Skip to main content

Stryker Corp(SYK-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low356.25
Day High368.25
Open:366.57
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Stryker Corp

Select a category then submit the form to load news
Tipranks
Stifel Nicolaus Keeps Their Buy Rating on Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Bioventus (BVS), Stryker (SYK) and Codexis (CDXS)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Surgery Partners (SGRY), Stryker (SYK)
Tipranks
Jefferies Reaffirms Their Buy Rating on Stryker (SYK)
Tipranks
Analysts Have Conflicting Sentiments on These Healthcare Companies: Immunome (IMNM), Hinge Health, Inc. Class A (HNGE) and Stryker (SYK)
Tipranks
RBC Capital Remains a Buy on Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Stevanato Group (STVN), Stryker (SYK) and Xencor (XNCR)
StockStory
1 S&P 500 Stock with Solid Fundamentals and 2 We Turn Down
QCOM
Tipranks
Analysts’ Top Healthcare Picks: Stryker (SYK), Tyra Bioscience (TYRA)
StockStory
1 Profitable Stock to Keep an Eye On and 2 We Turn Down
STNG
Tipranks
UBS Sticks to Their Hold Rating for Stryker (SYK)
Tipranks
Stryker (SYK) Gets a Buy from BTIG
Zacks Investment Research
AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech
AI-Driven Innovation Accelerates Tempus AI's Expansion Across MedTech
Zacks Investment Research
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
J&J's MedTech Shows Strong Growth in 2025: Will 2026 be Better?
Zacks Investment Research
BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?
BSX Posts Q4 Earnings: Should You Buy, Sell or Hold the Stock?
Zacks Investment Research
Should You Buy ISRG Stock Despite a 13% Fall in Three Months?
Should You Buy ISRG Stock Despite a 13% Fall in Three Months?
Zacks Investment Research
Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?
Can Intuitive Surgical Sustain Robust Top-line Growth in 2026?
GlobeNewswire
Stryker declares an $0.88 per share quarterly dividend
Tipranks
Stryker (SYK) Receives a Buy from Morgan Stanley
StockStory
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Challenges
TMHC
Tipranks
Wall Street Analysts Are Bullish on Top Healthcare Picks
Tipranks
Stryker (SYK) Earnings Call Highlights Growth and Resilience
Tipranks
Analysts Conflicted on These Healthcare Names: Resmed (RMD), Radiopharm Theranostics Limited Sponsored ADR (RADX) and Stryker (SYK)
Tipranks
Stryker (SYK) Gets a Buy from Jefferies
Tipranks
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Stryker (SYK) and Hologic (HOLX)
Tipranks
Analysts Are Bullish on Top Healthcare Stocks: Crinetics Pharmaceuticals (CRNX), Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), NewAmsterdam Pharma Company (NAMS) and Resmed (RMD)
Tipranks
RBC Capital Keeps Their Buy Rating on Stryker (SYK)
Tipranks
Analysts Offer Insights on Healthcare Companies: Stryker (SYK), Regeneron (REGN) and NewAmsterdam Pharma Company (NAMS)
Tipranks
Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and Dogwood Therapeutics (DWTX)
Motley Fool
Stryker (SYK) Q4 2025 Earnings Call Transcript
StockStory
Stryker’s (NYSE:SYK) Q4 CY2025 Sales Top Estimates
SYK

Profile

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic'products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg'products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.